Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01XUE
|
||||
Former ID |
DNCL003059
|
||||
Drug Name |
Tedatioxetine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Generalized anxiety disorder; Major depressive disorder [ICD9: 300, 300.02, 311, 296.2, 296.3, 710.0; ICD10:F32, F40-F42, F41.1, F33, M32] | Phase 1 | [548243] | ||
Company |
Lundbeck; Takeda Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H21NS
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)SC2=CC=CC=C2C3CCNCC3
|
||||
InChI |
1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3
|
||||
InChIKey |
CVASBKDYSQKLSO-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 508233-95-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 5-HT 3 receptor | Target Info | Modulator | [1572591] | |
5-hydroxytryptamine 2C receptor | Target Info | Modulator | [1572591] | ||
PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.